JPY 131.0
(3.15%)
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2023 | 5.53 Billion JPY | 4.38% |
2022 | 5.3 Billion JPY | 27.64% |
2021 | 4.15 Billion JPY | 124.67% |
2020 | 1.84 Billion JPY | -30.05% |
2019 | 2.64 Billion JPY | 2.44% |
2018 | 2.57 Billion JPY | 176.24% |
2017 | 933.85 Million JPY | 14.4% |
2016 | 816.3 Million JPY | 55.69% |
2015 | 524.29 Million JPY | 22.58% |
2014 | 427.72 Million JPY | -56.69% |
2013 | 987.61 Million JPY | 3.44% |
2012 | 954.81 Million JPY | 471.95% |
2011 | 166.93 Million JPY | 239.91% |
2010 | 49.11 Million JPY | 0.0% |
Year | Total Liabilities | Total Liabilities Growth |
---|---|---|
2024 Q1 | 5.25 Billion JPY | -4.98% |
2023 Q3 | 5.15 Billion JPY | -11.44% |
2023 Q2 | 5.82 Billion JPY | 0.56% |
2023 FY | 5.53 Billion JPY | 4.38% |
2023 Q1 | 5.79 Billion JPY | 9.24% |
2023 Q4 | 5.53 Billion JPY | 7.3% |
2022 Q2 | 5.13 Billion JPY | 60.59% |
2022 Q1 | 3.19 Billion JPY | -23.0% |
2022 FY | 5.3 Billion JPY | 27.64% |
2022 Q4 | 5.3 Billion JPY | 18.64% |
2022 Q3 | 4.46 Billion JPY | -12.99% |
2021 Q1 | 1.87 Billion JPY | 1.66% |
2021 Q3 | 2.51 Billion JPY | -1.17% |
2021 FY | 4.15 Billion JPY | 124.67% |
2021 Q4 | 4.15 Billion JPY | 65.36% |
2021 Q2 | 2.54 Billion JPY | 35.23% |
2020 Q4 | 1.84 Billion JPY | 2.03% |
2020 Q1 | 2.2 Billion JPY | -16.69% |
2020 FY | 1.84 Billion JPY | -30.05% |
2020 Q2 | 1.83 Billion JPY | -16.75% |
2020 Q3 | 1.81 Billion JPY | -1.16% |
2019 Q1 | 2.38 Billion JPY | -7.59% |
2019 FY | 2.64 Billion JPY | 2.44% |
2019 Q4 | 2.64 Billion JPY | 33.41% |
2019 Q3 | 1.98 Billion JPY | 1.67% |
2019 Q2 | 1.94 Billion JPY | -18.27% |
2018 Q3 | 874.84 Million JPY | -18.59% |
2018 Q2 | 1.07 Billion JPY | 2.87% |
2018 Q1 | 1.04 Billion JPY | 11.87% |
2018 FY | 2.57 Billion JPY | 176.24% |
2018 Q4 | 2.57 Billion JPY | 194.87% |
2017 Q3 | 681.04 Million JPY | -9.76% |
2017 Q1 | 740.73 Million JPY | -9.26% |
2017 FY | 933.85 Million JPY | 14.4% |
2017 Q4 | 933.85 Million JPY | 37.12% |
2017 Q2 | 754.65 Million JPY | 1.88% |
2016 Q2 | 596.65 Million JPY | 29.1% |
2016 FY | 816.3 Million JPY | 55.69% |
2016 Q3 | 585.97 Million JPY | -1.79% |
2016 Q4 | 816.3 Million JPY | 39.31% |
2016 Q1 | 462.16 Million JPY | -11.85% |
2015 FY | 524.29 Million JPY | 22.58% |
2015 Q1 | 438.44 Million JPY | 2.51% |
2015 Q3 | 461.24 Million JPY | 10.47% |
2015 Q4 | 524.29 Million JPY | 13.67% |
2015 Q2 | 417.52 Million JPY | -4.77% |
2014 Q4 | 427.72 Million JPY | 2.28% |
2014 Q2 | 232.8 Million JPY | -80.3% |
2014 Q3 | 418.18 Million JPY | 79.62% |
2014 Q1 | 1.18 Billion JPY | 19.64% |
2014 FY | 427.72 Million JPY | -56.69% |
2013 Q3 | 758.9 Million JPY | 3.68% |
2013 Q4 | 987.61 Million JPY | 30.14% |
2013 FY | 987.61 Million JPY | 3.44% |
2013 Q2 | 731.94 Million JPY | 5.12% |
2013 Q1 | 696.29 Million JPY | -27.07% |
2012 Q3 | 699.6 Million JPY | 238.23% |
2012 FY | 954.81 Million JPY | 471.95% |
2012 Q4 | 954.81 Million JPY | 36.48% |
2012 Q2 | 206.84 Million JPY | 6.28% |
2012 Q1 | 194.62 Million JPY | 16.59% |
2011 Q3 | 86.94 Million JPY | 20.39% |
2011 Q4 | 166.93 Million JPY | 92.01% |
2011 FY | 166.93 Million JPY | 239.91% |
2011 Q2 | 72.21 Million JPY | 0.0% |
2010 FY | 49.11 Million JPY | 0.0% |
Name | Total Liabilities | Total Liabilities Difference |
---|---|---|
DVx Inc. | 13.48 Billion JPY | 58.955% |
Seikagaku Corporation | 11.3 Billion JPY | 51.075% |
Eiken Chemical Co., Ltd. | 15.67 Billion JPY | 64.711% |
Create Medic Co., Ltd. | 4.31 Billion JPY | -28.244% |
PHC Holdings Corporation | 425.15 Billion JPY | 98.699% |
Techno Medica Co., Ltd. | 3.61 Billion JPY | -53.044% |
Rion Co., Ltd. | 8.2 Billion JPY | 32.544% |
Nihon Kohden Corporation | 52.14 Billion JPY | 89.39% |
Fukuda Denshi Co., Ltd. | 42.46 Billion JPY | 86.971% |
Japan Lifeline Co., Ltd. | 15.58 Billion JPY | 64.487% |
Japan Medical Dynamic Marketing, INC. | 5.88 Billion JPY | 5.935% |
CYBERDYNE Inc. | 9.52 Billion JPY | 41.899% |